AJP - Lung AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 283: L806-L814, 2002. First published June 5, 2002; doi:10.1152/ajplung.00061.2002
1040-0605/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/4/L806    most recent
00061.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venkatesan, N.
Right arrow Articles by Ludwig, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venkatesan, N.
Right arrow Articles by Ludwig, M. S.
Vol. 283, Issue 4, L806-L814, October 2002

Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta 1 and interferon-gamma

Narayanan Venkatesan1, Peter J. Roughley2, and Mara S. Ludwig1

1 Meakins-Christie Laboratories, Royal Victoria Hospital; and 2 Genetics Unit, Shriners Hospital for Crippled Children, McGill University, Montreal, Quebec, Canada H2X 2P2

Bleomycin (BM)-induced pulmonary fibrosis involves excess production of proteoglycans (PGs). Because transforming growth factor-beta 1 (TGF-beta 1) promotes fibrosis, and interferon-gamma (IFN-gamma ) inhibits it, we hypothesized that TGF-beta 1 treatment would upregulate PG production in fibrotic lung fibroblasts, and IFN-gamma would abrogate this effect. Primary lung fibroblast cultures were established from rats 14 days after intratracheal instillation of saline (control) or BM (1.5 units). PGs were extracted and subjected to Western blot analysis. Bleomycin-exposed lung fibroblasts (BLF) exhibited increased production of versican (VS), heparan sulfate proteoglycan (HSPG), and biglycan (BG) compared with normal lung fibroblasts (NLF). Compared with NLF, BLF released significantly increased amounts of TGF-beta 1. TGF-beta 1 (5 ng/ml for 48 h) upregulated PG expression in both BLF and NLF. Incubation of BLF with anti-TGF-beta antibody (1, 5, and 10 µg/ml) inhibited PG expression in a dose-dependent manner. Treatment of BLF with IFN-gamma (500 U · ml-1 × 48 h) reduced VS, HSPG, and BG expression. Furthermore, IFN-gamma inhibited TGF-beta 1-induced increases in PG expression by these fibroblasts. Activation of fibroblasts by TGF-beta 1 promotes abnormal deposition of PGs in fibrotic lungs; downregulation of TGF-beta 1 by IFN-gamma may have potential therapeutic benefits in this disease.

lung fibrosis; versican; heparan sulfate proteoglycan; biglycan


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
D. S. Faffe and W. A. Zin
Lung Parenchymal Mechanics in Health and Disease
Physiol Rev, July 1, 2009; 89(3): 759 - 775.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. R. Kliment, J. M. Englert, B. R. Gochuico, G. Yu, N. Kaminski, I. Rosas, and T. D. Oury
Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis
J. Biol. Chem., February 6, 2009; 284(6): 3537 - 3545.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. V. Gonzalez, F. Le Bellego, and M. S. Ludwig
Imbalance of Receptor-Regulated and Inhibitory Smads in Lung Fibroblasts from Bleomycin-Exposed Rats
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 206 - 212.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. A Pacanowski and G. W Amsden
Interferon Gamma-1b in the Treatment of Idiopathic Pulmonary Fibrosis
Ann. Pharmacother., October 1, 2005; 39(10): 1678 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Fust, F. LeBellego, R. V. Iozzo, P. J. Roughley, and M. S. Ludwig
Alterations in lung mechanics in decorin-deficient mice
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L159 - L166.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Venkatesan, L. Pini, and M. S. Ludwig
Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1342 - L1347.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Larsen, E. Tufvesson, J. Malmstrom, M. Morgelin, M. Wildt, A. Andersson, A. Lindstrom, A. Malmstrom, C.-G. Lofdahl, G. Marko-Varga, et al.
Presence of Activated Mobile Fibroblasts in Bronchoalveolar Lavage from Patients with Mild Asthma
Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1049 - 1056.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online